>
Switch to:

Orgenesis Piotroski F-Score

: 2 (As of Today)
View and export this data going back to 2010. Start your Free Trial

Warning Sign:

Piotroski F-Score of 2 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Orgenesis has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Orgenesis's Piotroski F-Score or its related term are showing as below:

NAS:ORGS' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 4   Max: 6
Current: 2

2
6

During the past 13 years, the highest Piotroski F-Score of Orgenesis was 6. The lowest was 2. And the median was 4.


Orgenesis Piotroski F-Score Historical Data

The historical data trend for Orgenesis's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orgenesis Annual Data
Trend Nov11 Nov12 Nov13 Nov14 Nov15 Nov16 Nov17 Nov18 Dec19 Dec20
Piotroski F-Score
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.00 4.00 5.00 4.00 5.00

Orgenesis Quarterly Data
Nov16 Feb17 May17 Aug17 Nov17 Feb18 May18 Aug18 Nov18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
Piotroski F-Score Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 5.00 3.00 2.00 2.00

Competitive Comparison

For the Biotechnology subindustry, Orgenesis's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Orgenesis Piotroski F-Score Distribution

For the Biotechnology industry and Healthcare sector, Orgenesis's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Orgenesis's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep21) TTM:Last Year (Sep20) TTM:
Net Income was -46.038 + -0.219 + -2.659 + -10.159 = $-59.08 Mil.
Cash Flow from Operations was -45.227 + -4.547 + -11.5 + -8.355 = $-69.63 Mil.
Revenue was 2.296 + 9.389 + 10.545 + 8.676 = $30.91 Mil.
Gross Profit was -1.908 + 4.238 + 3.02 + 1.552 = $6.90 Mil.
Average Total Assets from the begining of this year (Sep20)
to the end of this year (Sep21) was
(110.752 + 77.684 + 82.11 + 75.558 + 65.204) / 5 = $82.2616 Mil.
Total Assets at the begining of this year (Sep20) was $110.75 Mil.
Long-Term Debt & Capital Lease Obligation was $7.99 Mil.
Total Current Assets was $36.34 Mil.
Total Current Liabilities was $13.57 Mil.
Net Income was -6.06 + 69.981 + -20.406 + -2.427 = $41.09 Mil.

Revenue was -20.28 + 1.878 + 1.749 + 1.729 = $-14.92 Mil.
Gross Profit was -16.95 + -0.105 + -20.223 + -0.73 = $-38.01 Mil.
Average Total Assets from the begining of last year (Sep19)
to the end of last year (Sep20) was
(79.599 + 92.495 + 127.209 + 119.196 + 110.752) / 5 = $105.8502 Mil.
Total Assets at the begining of last year (Sep19) was $79.60 Mil.
Long-Term Debt & Capital Lease Obligation was $11.24 Mil.
Total Current Assets was $94.98 Mil.
Total Current Liabilities was $12.36 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Orgenesis's current Net Income (TTM) was -59.08. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Orgenesis's current Cash Flow from Operations (TTM) was -69.63. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Sep20)
=-59.075/110.752
=-0.53339895

ROA (Last Year)=Net Income/Total Assets (Sep19)
=41.088/79.599
=0.51618739

Orgenesis's return on assets of this year was -0.53339895. Orgenesis's return on assets of last year was 0.51618739. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Orgenesis's current Net Income (TTM) was -59.08. Orgenesis's current Cash Flow from Operations (TTM) was -69.63. ==> -69.63 <= -59.08 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Sep21)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep20 to Sep21
=7.989/82.2616
=0.097117

Gearing (Last Year: Sep20)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep19 to Sep20
=11.244/105.8502
=0.10622559

Orgenesis's gearing of this year was 0.097117. Orgenesis's gearing of last year was 0.10622559. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Sep21)=Total Current Assets/Total Current Liabilities
=36.341/13.566
=2.67882943

Current Ratio (Last Year: Sep20)=Total Current Assets/Total Current Liabilities
=94.983/12.355
=7.6878187

Orgenesis's current ratio of this year was 2.67882943. Orgenesis's current ratio of last year was 7.6878187. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Orgenesis's number of shares in issue this year was 24.275. Orgenesis's number of shares in issue last year was 22.094. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=6.902/30.906
=0.22332233

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=-38.008/-14.924
=2.5467703

Orgenesis's gross margin of this year was 0.22332233. Orgenesis's gross margin of last year was 2.5467703. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Sep20)
=30.906/110.752
=0.27905591

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Sep19)
=-14.924/79.599
=-0.18748979

Orgenesis's asset turnover of this year was 0.27905591. Orgenesis's asset turnover of last year was -0.18748979. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+0+1+0+0+0+1
=2

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Orgenesis has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

Orgenesis  (NAS:ORGS) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Orgenesis Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Orgenesis's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Orgenesis Business Description

Orgenesis logo
Industry
Healthcare » Biotechnology NAICS : 325412 SIC : 2834
Traded in Other Exchanges
Address
20271 Goldenrod Lane, Germantown, MD, USA, 20876
Orgenesis Inc is a part of the healthcare sector. It is a fully-integrated biopharmaceutical company focused on developing trans-differentiation technologies for diabetes and vertically integrating manufacturing that can optimize its abilities to scale-up its technologies for clinical trials and eventual commercialization. The group operates in two segments namely CDMO and POC. The company is also engaged in applying its disciplined execution to emerging technologies of other cell therapy markets in such areas as cell-based cancer immunotherapies and neurodegenerative diseases.
Executives
Sidransky David director JOHNS HOPKINS UNIVERSITY 720 RUTLAND AVENUE BALTIMORE MD 21205
Reithinger Neil officer: CFO, Treasurer and Secretary 14950 N. 83RD PLACE SUITE 1 SCOTTSDALE AZ 85260
Philips Mario director C/O ATMI, INC DANBURY CT 06810
Ferber Sarah officer: Chief Scientific Officer 17B HAHASKALA STREET TEL AVIV L3 67890
Yachin Guy director 7 ORCHARD WAY N POTOMAC MD 20854
Nanda Ashish director 2301, 23RD FLOOR, TIFFANY TOWERS CLUSTER W, JLT, DUBAI, UAE DUBAI C0 4452
Bedoret Denis officer: See Remarks 48, RUE AUGUSTE PICCARD GOSSELIES C9 6041
Universite Libre De Bruxelles other: less than 10% AVENUE F, ROOSEVELT, 50 BRUSSELS C9 1050
Theodorus Ii Sa other: less than 10% ALLEE DE LA RECHERCHE, 12 BRUSSELS C9 1070
Theodorus Sca other: less than 10% ALLEE DE LA RECHERCHE, 12 BRUSSELS C9 1070
Belenger Olivier other: less than 10% DIEWEG, 69 BRUSSELS C9 1070
Shvartz Oded 10 percent owner 130 BIRUINTEI BVD. PANTELIMON, ILFOV S5 0000000
Bultot Hugues director AVENUE DE L??HORIZON 24 WOLUWE SAINT PIERRE C9 1150
Buyse Chris Georges Frans director BAILLET LATOURLEI 119A BRUSSELS C9 2390
Tenne Joseph officer: CFO Treasurer Secretary 6225 NEIL ROAD, SUITE 300 C/O ORMAT TECHNOLOGIES, INC. RENO NV 89511

Orgenesis Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)